• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2400436 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-07-09 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
CXSL2400293 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2024-05-09 Shandong New Time Pharmaceutical Co Ltd view
JYSB2400035 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.1) Supplementary Application 2024-02-27 Novo Nordisk A/S view
CXSL2400105 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-07 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2400082 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-01 view
JYSB2400021 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2024-02-01 view
CXSL2300515 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-07-26 Jilin Huisheng Biopharmaceutical Co Ltd view
CXSL2300433 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2023-06-27 Wanbang Biopharmaceuticals view
CXSL2300092 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-02-08 Federal Biotechnology (Zhuhai Hengqin) Co Ltd view
CYSB2300007 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2023-01-11 Novo Nordisk (China) Pharmaceuticals Co Ltd view
JYSB2200188 德谷胰岛素注射液 insulin degludec Injection Biological Products Supplementary Application 2022-09-29 Novo Nordisk A/S view
JYSB2200187 德谷胰岛素注射液 insulin degludec Injection Biological Products Supplementary Application 2022-09-29 Novo Nordisk A/S view
CYSB2200227 德谷胰岛素注射液 insulin degludec Injection Biological Products Supplementary Application 2022-09-15 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CYSB2200226 德谷胰岛素注射液 insulin degludec Injection Biological Products Supplementary Application 2022-09-15 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CXSL2200458 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-09-14 Wanbang Biopharmaceuticals view
CXSL2200411 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2022-08-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2200319 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-07-25 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2200318 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-07-25 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSS2200066 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-07-15 Jilin Huisheng Biopharmaceutical Co Ltd view
CXSS2200067 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-07-15 Jilin Huisheng Biopharmaceutical Co Ltd view